InMed Pharmaceuticals
INM • NASDAQ
InMed Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric A. Adams Chem., with a market cap of $2.6M.
CEOEric A. Adams Chem.
Market Cap$2.6M
Biotechnology
Healthcare
Employees13.0
Websiteinmedpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for InMed Pharmaceuticals
Date
Monday, May 11, 2026 (in 3 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q3 2026
Earnings History
Past 11 earnings reports for InMed Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | Q1 2026 | -$0.44 | — | $1.1M | — |  10-Q |
| Sep 23, 2025 | Q4 2025 | -$0.43 | — | $1.3M | — | 10-K |
| May 12, 2025 | Q3 2025 | -$1.94 | — | $1.3M | — | 10-Q |
| Feb 12, 2025 | Q2 2025 | -$3.64 | — | $1.1M | — | 10-Q |
| Nov 14, 2024 | Q1 2025 | -$2.71 | — | $1.3M | — | 10-Q |
| Sep 30, 2024 | Q4 2024 | -$3.80 | — | $1.3M | — | 10-K |
| May 14, 2024 | Q3 2024 | -$3.60 | — | $1.2M | — | 10-Q |
| Feb 13, 2024 | Q2 2024 | -$3.80 | — | $1.2MEst: $1.4M | -10.8% | 10-Q |
| Nov 14, 2023 | Q1 2024 | -$15.20 | — | $901.9K | — | — |
| Sep 19, 2023 | Q4 2023 | $5.60 | — | $2.3M | — | 10-K |
| May 15, 2023 | Q3 2023 | -$12.00 | — | $1.0M | — | 10-Q |